Treating Cancer Cachexia
Author Information
Author(s): Lee Se-Jin, Glass David J
Primary Institution: Johns Hopkins University School of Medicine
Hypothesis
Can blocking the myostatin/activin signaling pathway help treat cancer cachexia?
Conclusion
Blocking the myostatin/activin signaling pathway can significantly improve muscle mass and survival in cancer cachexia models.
Supporting Evidence
- Blocking the myostatin/activin pathway preserved muscle mass in mice.
- The soluble receptor increased survival in mice with cancer without affecting tumor growth.
- Mice treated with the soluble receptor showed improved grip strength.
Takeaway
This study suggests that stopping certain signals in the body can help people with cancer keep their muscles and feel better.
Methodology
The commentary discusses findings from two studies that blocked the myostatin/activin signaling pathway in mouse models of cancer cachexia.
Potential Biases
Potential conflicts of interest due to authors' affiliations with pharmaceutical companies.
Limitations
The commentary does not provide specific limitations but notes that further studies are needed to understand the role of the signaling pathway in cachexia.
Participant Demographics
The studies referenced involved mouse models.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website